Fig 4.tif (273.86 kB)
BEMER therapy radiosensitizes microtumors.
figure
posted on 2016-12-13, 18:46 authored by Katja Storch, Ellen Dickreuter, Anna Artati, Jerzy Adamski, Nils Cordes(A) Flow chart of colony formation assay. (B) Basal surviving fraction of BEMER (~13 μT, 8 min, 1 h, 24 h) treated and BEMER sham-treated (sham) microtumors. (C) Clonogenic survival after BEMER therapy (~13 μT, 8 min, 1 h, 24 h) combined with radiotherapy (2 and 6 Gy). All results represent mean ± SD. Student's t-test compares BEMER therapy versus sham samples. n = 3. * P < 0.05; ** P < 0.01.
History
Usage metrics
Categories
Keywords
Cancer Cell Radioresistancemolecular-targeted agent Cetuximabalternative medicinePhysical Vascular TherapyBEMER therapymolecular-targeted agentscancer cell radiosensitizationtricarboxylic acid cycle pathwaysBEMER Electromagnetic Field Therapycancer cell survivalepidermal growth factor receptorapproachlow-dose electromagnetic fieldsmultimodal therapiesEnhanced ROS Formationreactive oxygen speciesapplication areasBEMER treatmentchemotherapytherapy personalizationtumor biologyradiotherapyInduced DNA Damagecancer cell linesmatrix-based cell culture modelsEMF pattern impactsEMF patternnovel possibilitiesBEMER EMF pattern
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC